Cite
HARVARD Citation
Genovese, M. et al. (n.d.). FRI0228 Sarilumab Dose Reduction To Manage Laboratory Abnormalities in An Open-Label Extension Study in RA Patients. Annals of the rheumatic diseases. pp. 515-516. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Genovese, M. et al. (n.d.). FRI0228 Sarilumab Dose Reduction To Manage Laboratory Abnormalities in An Open-Label Extension Study in RA Patients. Annals of the rheumatic diseases. pp. 515-516. [Online].